Trulieve Cannabis Q2 revenue falls on Harvest deconsolidation

Trulieve Cannabis ( Delaware )

07/08/2026 11:31

((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
Overview
    * US medical cannabis firm's Q2 revenue fell 10% yr/yr to $271 mln after Harvest deconsolidation
    * Adjusted EPS for Q2 was $0.11, with adjusted net income of $20 mln
    * Company announced share repurchase program up to $50 mln or 8.5 mln shares

Outlook
    * Company expects growth opportunities from broader cannabis rescheduling and state program expansion

Result Drivers
    * HARVEST DECONSOLIDATION - Co said revenue decline and net loss were primarily due to deconsolidation of Harvest operations and related equity investment
    * RETAIL SALES DOMINANCE - Retail sales accounted for 94% of Q2 revenue
    * GEORGIA EXPANSION - Co began shipment of medical cannabis products to licensed independent pharmacies in Georgia and launched new products in the state

Company press release:  ID:nPn5LGpkpa 
Key Details
 Metric    Beat/Mis  Actual    Consensu
           s                   s
                               Estimate
 Q2                  $271 mln   
 Revenue                       
 Q2                  $0.11      
 Adjusted                      
 EPS                           
 Q2 Loss             $2.10      
 Per                           
 Share                         
 Q2                  $20 mln    
 Adjusted                      
 Net                           
 Income                        
 Q2                  $98 mln    
 Adjusted                      
 EBITDA                        
 Q2 Gross            60.00%     
 Margin                        
 Analyst Coverage
    * The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
    * Wall Street's median 12-month price target for Trulieve Cannabis Corp. is $20.00, about 122.2% above its August 6 closing price of $9.00

Reuters Recommended Reads
    * Aug 5 - Curaleaf Q2 revenue beats analyst estimates on domestic growth
    * Aug 5 - Verano Q2 revenue tops estimates on retail expansion
    * Aug 6 - Cresco Labs Q2 revenue beats estimates

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)